100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in both
Our Recommendation
Nimonidip 30mg Tablet 10s
1,574+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Subarachnoid haemorrhage
Customers also bought
More About Nimodip 30mg Tablet 10s
Benefits
In Subarachnoid haemorrhage Nimodip Tablet is a calcium channel blocker. It works by relaxing the narrowed blood vessels in the brain so that blood can flow more easily. This prevents further brain damage after bleeding around the brain. It is usually started as soon as possible after the start of bleeding in the brain. Take it as per the dose and duration suggested by your doctor. If you stop taking it suddenly, your condition may worsen.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Nimodip Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Nimodip Tablet is a calcium channel blocker. It relaxes the narrow blood vessels in the brain and makes the blood flow more easily. This prevents brain damage after bleeding around the brain.
Unsafe: Avoid consuming alcohol with Nimodip Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Nimodip Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Nimodip Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Nimodip Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Nimodip Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nimodip Tablet may not be needed in these patients. Doctor consultation is advised.
Caution Advised: Nimodip Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Nimodip Tablet may be needed. Doctor consultation is advised.
Manufacturer Address
Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai - 400 088. , India.
References
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 980-82
Nimodipine. Pointe-Claire, Canada: Importfab; 1988 (23 Jan. 2019)
Nimodipine. Leverkusen, Germany: Bayer AG; 2017 (20 Mar. 2019)
Nimodipine. St. Petersburg, Florida: Cardinal Health; 2005 (20 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
